EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression

Philip Kienzl, Abigail J Deloria, Monika Hunjadi, Juliane M Hadolt, Max-Felix Haering, Angrit Bothien, Doris Mejri, Medina Korkut-Demirbaş, Sandra Sampl, Gerhard Weber, Christine Pirker, Severin Laengle und 11 weitere

Cellular Oncology · 2025-02 · 48 (1) · 239-247

DOI: 10.1007/s13402-024-00986-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 02.09.2024. Verfasst von Philip Kienzl und 22 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, Vienna, A-1090, Austria. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Proliferating Cell Nuclear Antigen, Telomere. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Telomeric repeat-containing RNAs (TERRA) and telomerase RNA component (TERC) regulate telomerase activity (TA) and thereby contribute to telomere homeostasis by influencing telomere length (TL) and the cell immortality hallmark of cancer cells. Additionally, the non-canonical functions of telomerase reverse transcriptase (TERT) and TERRA appear to be involved in the epithelial-mesenchymal transition (EMT), which is important for cancer progression. However, the relationship between TERRA and patient prognosis has not been fully characterized. In this small-scale study, 68 patients with colorectal cancer (CRC) were evaluated for correlations between telomere biology, proliferation, and EMT gene transcripts and disease outcome. The proliferating cell nuclear antigen (PCNA) and the epithelial splicing regulatory proteins 1 and 2 (ESRP1 and ESRP2) showed a positive correlation with TERRA, while TA and TERRA exhibited an inverse correlation. Consistent with previous findings, the present study revealed higher expression levels of TERT and TERC, and increased TA and TL in CRC tumor tissue compared to adjacent non-tumor tissue. In contrast, lower expression levels of TERRA were observed in tumor tissue. Patients with high TERRA expression and low PCNA levels exhibited favorable overall survival rates compared to individuals with the inverse pattern. Furthermore, TERRA suppressed CRC tumor growth in severe combined immunodeficiency disease (SCID) mice. In conclusion, our study extends previously published research on TERRA suggesting its potential therapeutic role in telomerase-positive CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsProliferating Cell Nuclear AntigenTelomereHumansPrognosisAnimalsFemaleMaleTelomeraseMiddle AgedMiceGene Expression Regulation, NeoplasticEpithelial-Mesenchymal TransitionAgedCell Line, TumorCell ProliferationRNA

Stichwörter der Autor:innen

Colorectal cancer survivalCorrelation studyTelomere and proliferation parametersTumor progression

Substanzen

Proliferating Cell Nuclear AntigenTelomeraseRNAtelomerase RNA

Autor:innen und Institutionen

  • Center for Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, Vienna, A-1090, Austria.
  • Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
  • Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
  • Department of Surgery, Social Medical Center South, Kaiser Franz Josef Hospital, Vienna, Austria.
  • Department of Surgery, Klinik Floridsdorf, Wiener Gesundheitsverbund, Vienna, Austria.

Förderung

  • Medical University of Vienna

Zitieren

APA

Kienzl, P., Deloria, A. J., Hunjadi, M., Hadolt, J. M., Haering, M. F., Bothien, A., Mejri, D., Korkut-Demirbaş, M., Sampl, S., Weber, G., Pirker, C., Laengle, S., Braunschmid, T., Dragona, E., Marian, B., Gagos, S., Lu, L., Henson, J. D., Lau, L. M. S., …, & Holzmann, K. (2025). Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression. Cellular Oncology, 48(1), 239-247. https://doi.org/10.1007/s13402-024-00986-y

Vancouver

Kienzl P, Deloria AJ, Hunjadi M, Hadolt JM, Haering MF, Bothien A, et al. Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression. Cellular Oncology. 2025;48(1):239-247. doi:10.1007/s13402-024-00986-y

BibTeX
@article{Kienzl2025,
  author = {Kienzl, Philip and Deloria, Abigail J and Hunjadi, Monika and Hadolt, Juliane M and Haering, Max-Felix and Bothien, Angrit and Mejri, Doris and Korkut-Demirbaş, Medina and Sampl, Sandra and Weber, Gerhard and Pirker, Christine and Laengle, Severin and Braunschmid, Tamara and Dragona, Eleni and Marian, Brigitte and Gagos, Sarantis and Lu, Lingeng and Henson, Jeremy D and Lau, Loretta M S and Reddel, Roger R and Mikulits, Wolfgang and Stättner, Stefan and Holzmann, Klaus},
  title = {Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression},
  journal = {Cellular Oncology},
  year = {2025},
  volume = {48},
  number = {1},
  pages = {239--247},
  doi = {10.1007/s13402-024-00986-y}
}
Kostenlos starten →